Malaysian Research Partnership

Partnership objectives

  1. Build win-win relationship between the natural products holder and user (company).
  2. Help capacity building in Malaysia in the field of basic research, i.e. screening techniques.
  3. Help to enrich the research equipment at the laboratory.

Astellas is supporting the construction and development of a research infrastructure in Malaysia for new drug discovery based on micro-organisms. Astellas is supporting the construction and development of a research infrastructure in Malaysia for new drug discovery based on micro-organisms. Copyright Astellas

Description of partnership activities and how they address needs and challenges

Since 2001, Astellas has been involved in a partnership with the Research Institute of Malaysia (SIRIM), a Malaysian state-owned enterprise, and TropBio, an Australian biotech company, for collaborative research based on micro-organisms.

This partnership is in accordance with the spirit of the Convention on Biological Diversity and incorporates redistribution of benefits to the country of origin. Under this agreement, researchers from Astellas in Japan work together with Malaysian researchers to collect microorganism samples from the Malay Peninsula to be screened for potential use in drug development.

Astellas has conducted new drug discovery based on exact screening of micro-organisms for nearly 40 years and has accumulated fundamental technologies for biological research with microbial products, focussing on tropical rainforests where biological diversity is the greatest in the world.

The partnership contract contains a clause which stipulates that Astellas provide biological research technologies to Malaysia and share the rewards of any joint successes. Astellas accordingly provided 8 trainees from Malaysia with hands-on training in its own research laboratories.

The training program covers the isolation, culture, and screening of targeted micro-organisms. In addition, Astellas is supporting the construction and development of a research infrastructure in Malaysia for new drug discovery based on micro-organisms. This partnership helps Malaysia to introduce advanced technology from abroad, while Astellas is able to broaden its research efforts.

Capacity building in research is important for conducting drug discovery research in Malaysia. While Astellas obtains the seeds for drug discovery research from the natural Malaysian products, Malaysian researchers learn the advanced technologies for drug discovery research and obtain up-to-date equipment for research from Astellas.

Summary of impact through December 2013 and forward looking information

In total eight (8) Malaysian researchers stayed in Japan for six (6) months each, and many researchers received the on-site training in the laboratory in Malaysia.

Partnership information

Company(ies) Astellas

Partner(s) Standards & Industrial Research Institute of Malaysia, TropBio

Type of Partner(s) Academia / Hospitals

Therapeutic Focus Other

Disease(s) General Health

Program Type(s) Availability of Treatment - Technology Transfer - Manufacturing and Entrepreneurial Know-How, Availability of Treatment - Technology Transfer - Scientific Collaboration and Knowledge Sharing, Health System Infrastructure - Development of Physical Infrastructure, Health System Infrastructure - Training, Research & Development - Development of Treatments

Targeted Population(s) Health professionals

Region(s) East Asia & Pacific

Number of Countries 2

Country(ies) Japan, Malaysia

Research Country(ies) Malaysia

Start Date 2000

More information Astellas Access to Health

Completed date 2013